Clinical Research Directory
Browse clinical research sites, groups, and studies.
BioHealx® Anal Fistula Device Post Market Surveillance Study
Sponsor: Signum Surgical USA Inc.
Summary
This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2025-06-14
Completion Date
2026-12
Last Updated
2026-04-08
Healthy Volunteers
No
Conditions
Interventions
BioHealx
Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening, preventing reinfection, while allowing for drainage through the external opening during healing.
Locations (5)
The Colorectal Institute
Fort Myers, Florida, United States
Weill Cornell Medicine
New York, New York, United States
Northwell Health
Staten Island, New York, United States
Maininle Health Lankenau
Bryn Mawr, Pennsylvania, United States
Geisinger
Danville, Pennsylvania, United States